Related Experiment Videos
Anesthetic considerations in the child with Gaucher disease
1Department of Pediatrics, Vanderbilt University, Nashville, TN 37232.
Insights
Anesthetic management for Gaucher disease requires careful consideration of potential complications. Preoperative assessment of end-organ dysfunction is crucial for safe pediatric surgical care.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Anesthesiology
Background:
- Gaucher disease is an inherited metabolic disorder caused by deficient glucosylceramide beta-glucosidase activity.
- This deficiency leads to the accumulation of glycosphingolipids, causing progressive end-organ damage.
- Three clinical variants exist, differing in onset, central nervous system (CNS) involvement, and prevalence.
Observation:
- A 7-month-old girl with Gaucher disease underwent anesthesia for laryngoscopy, bronchoscopy, and central line placement.
- Potential anesthetic concerns include CNS dysfunction (seizures, aspiration risk), upper airway obstruction from glycolipid infiltration, and bleeding risks due to hypersplenism (thrombocytopenia, anemia).
Findings:
- Gaucher disease presents significant anesthetic challenges due to multi-system involvement.
- Anesthesiologists must be aware of specific risks associated with CNS, airway, and hematologic complications.
- Preoperative evaluation is key to identifying and managing these risks.
Implications:
- Early identification of end-organ dysfunction in pediatric Gaucher disease patients is vital for anesthetic planning.
- This case highlights the importance of a multidisciplinary approach for managing complex pediatric cases.
- Optimizing preoperative assessment can ensure safer anesthetic delivery and improved patient outcomes.
Abstract:
We present the case of a 7-month-old girl with Gaucher disease who required anesthetic care during laryngoscopy, bronchoscopy, and central line placement. Gaucher disease is a familial disorder of lipid catabolism with autosomal recessive inheritance. Due to the defective function of the enzyme glucosylceramide beta-glucosidase, glycosphingolipids accumulate, leading to end-organ dysfunction. Three clinical variants of the disease, which differ in age of onset, degree of central nervous system (CNS) involvement, and frequency in the population, have been described. Of concern to the anesthesiologist is the occurrence of significant CNS dysfunction in types II and III, with seizures, gastroesophageal reflux, and chronic aspiration. Bulbar involvement and infiltration of the upper airway with glycolipids may lead to upper airway obstruction. Additionally, hepatosplenomegaly, present in all three variants, may lead to hypersplenism with thrombocytopenia and anemia. Preoperative identification of the associated end-organ dysfunction will allow the safe provision of anesthetic care for these children.